hCRF

DRUG2 trials

Sponsors

Celtic Pharma Development Services

Conditions

Brain EdemaBrain Tumor

Phase 3

XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors

CompletedNCT00088166

Celtic Pharma Development ServicesBrain Edema, Brain Tumor

Start: 2004-05-31End: 2008-03-31Updated: 2014-08-13

XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema

WithdrawnNCT00226668

Celtic Pharma Development ServicesBrain Edema, Brain Tumor

Start: 2006-01-31End: 2008-01-31Target: 120Updated: 2008-01-03